APREPSORA 30MG (Apremilast (30mg))

Aprepsora 30mg Tablet is indicated for the management of moderate to severe plaque psoriasis, a dermatological condition characterized by raised, red patches covered with silvery scales. This medication is considered when traditional therapies are unsuitable, ineffective, or poorly tolerated by the patient. It can be taken with or without food, but it is crucial to adhere to the prescribed regimen and to not discontinue use prematurely, even if symptoms improve, unless advised by a healthcare professional. Regular monitoring of body weight is advised, as this medication can potentially lead to weight loss during treatment. While using Aprepsora, patients may experience a variety of common adverse effects, including nausea, diarrhea, vomiting, headaches, and respiratory infections affecting the upper tract. Should these symptoms persist or worsen, it is important to communicate this to your healthcare provider, who may recommend alternative treatments or adjustments to the dosage. Prior to initiating treatment, individuals should disclose all medications they are currently taking to their doctor to ensure safety and prevent interactions. Patients who are pregnant or breastfeeding should also seek guidance from their physician before starting this medication. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.